Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1227 | 934 | 1227 | 1735 | 3018 | 4539 |
Fund Return | 22.7% | -6.65% | 22.7% | 20.16% | 24.72% | 16.33% |
Place in category | 149 | 168 | 149 | 99 | 93 | 77 |
% in Category | 79 | 90 | 79 | 65 | 63 | 62 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
INF277K01Z77 | 126.59B | 32.37 | 11.38 | - | ||
Tata Digital India Regular Growth | 126.59B | 30.62 | 9.74 | - | ||
INF277K010S4 | 102.58B | 10.76 | 10.98 | - | ||
INF277K011O1 | 95.72B | 33.54 | 25.94 | - | ||
Tata Balanced Fund Direct Plan Div | 41.5B | 14.08 | 13.10 | 10.94 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
HDFC MidCap Opportunities Div | 760.61B | 28.60 | 27.74 | 17.82 | ||
HDFC MidCap Opportunities Growth | 760.61B | 28.62 | 27.78 | 18.10 | ||
HDFC MidCap Opportunities Dir Div | 760.61B | 29.47 | 28.62 | 18.84 | ||
HDFC MidCap Opportunities Dir Gr | 760.61B | 29.47 | 28.66 | 19.06 | ||
Kotak Emerging Equity Scheme Divide | 520.49B | 33.55 | 22.68 | 18.30 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Muthoot Finance | INE414G01012 | 3.30 | 2,172.45 | -1.03% | |
Max Financial | INE180A01020 | 3.20 | 1,039.85 | -1.57% | |
Alkem Laboratories Ltd | INE540L01014 | 3.11 | 5,021.00 | -3.13% | |
Aurobindo Pharma | INE406A01037 | 2.95 | 1,211.55 | -2.67% | |
Jubilant FoodWorks Ltd | INE797F01020 | 2.85 | 671.05 | -2.42% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review